3Badros A,Barlogie B,Siegel E,et al.Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years.Br J Haematol,2001,114(3):600～607. 被引量：1
4Ferrara F,Venditti A,Carellajr AM,et al.Autologous stem-cell transplantation for patients with acute myeloid leukemia aged over 60 yr.Eur J Haematol,2002,69(2):200 ～ 204. 被引量：1
5Scheid C,DraubeA,Reiser M,et al.Usingat least5× 106/kgCD34 + cells for autologous stem cell transplantation significantly reduces febrile complications and use of antibiotics after transplantation.Bone Marrow Transplantation,1999,23(11):1177 ～ 1181. 被引量：1
6Ferrara F,Palmieri S,Annunziata M,et al.Continuous infusion idarubicin and oral busulfan as conditioning for patients with acute myeloid leukemia aged over 60 years undergoing autologous stem cell transplantation.Bone Marrow Transplantation,2004,34(7):573 ～ 576. 被引量：1
7张之南等主编..协和血液病学[M].北京:中国协和医科大学出版社,2004:835.
8Rubia J,Saavedra S,Sanz GF,et al.Transplant-related mortality in patients older than 60 years undergoing autologous hematopoietic stem cell transplantation.Bone Marrow Transplantation,2001,27 (1):21 ～ 25. 被引量：1
9San Miguel JF,Lahuerta JJ,Garcia-Sanz R,et al.Are myeloma patients with renal failure candidates for autologous stem cell transplantation? Hematol J,2000,1 (1):26 ～ 28. 被引量：1
2Weaver CH, Schwartzcerg L, Zhen B et al. High-dose chemotherapy and peripheral blood stem cell infusion in patients with non-Hodgkin′s lymphoma: results of outpatient treatment in community cancer centers. Bone Marrow Transpl, 1997, 20:753-760. 被引量：1
3Reece DE, Barnett M J, Shepherd JD, et al. High-dose sequential chemotherapy with peripheral blood progeniter cell support for relapsed or refractory Hodgkin′s disease: a 6-year update, Ann Oncol, 1993, 4:889-891. 被引量：1
4Sweetenham JN, Liberti G, Pearce R, et al. High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: results of European group for BMT. J Clin Oncol, 1994,12:1358-1365. 被引量：1
5Linch DC, Winfield D, Goldstone AH, et al. Dose intensification with autologous bone marrow transplantation in relapsed and resistant Hodgkin′s disease: results of a randomized trial. Lancet, 1993,314:1051-1053. 被引量：1
6Phillips GL, Garella A, Goldstone S, et al. Intensive therapy and hematopoietic stem cell rescue in Lymphoma: summary of the keystone lymphoma workshop. Bone Marrow Transpl, 1995,15:229-231. 被引量：1
7Vicki A, Bruce A. High-dose therapy and transplantation in nonHodgkin′s lymphoma. Semin Oncol, 1999,26:84-85. 被引量：1
